Kodiak Sciences Inc. (KOD) stock
KODNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$111.19+2.94 (+2.72%)
Close on Nov 13, 2026Market cap $6.99BP/E –Yield –
Kodiak Sciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Kodiak Sciences's enterprise value was $6.74B on Nov 11, 2026, against $1.15B a year earlier. Over the last 5 years it ranged from -$419.52M to $6.74B, with a median of -$20.18M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $6.74B | +378.4% |
| 2025 | Dec 31, 2025 | $1.41B | +332.8% |
| 2024 | Dec 31, 2024 | $325.74M | – |
| 2023 | Dec 29, 2023 | -$186.17M | – |
| 2022 | Dec 30, 2022 | -$162.90M | -104.5% |
| 2021 | Dec 31, 2021 | $3.58B | -42.2% |
| 2020 | Dec 31, 2020 | $6.20B | +138.1% |
| 2019 | Dec 31, 2019 | $2.60B | +5645.2% |
| 2018 | Dec 31, 2018 | $45.29M | – |
See a number that looks wrong?